The Boston private equity firm Yellow Wood Partners will pay US$585 million for Bayer's Doctor Scholl's business, which generated US$234 million in revenues last year.
The deal - which represents a premium of some 68% over Loxo Oncology's closing share price on Friday - is expected to close by the end of the first quarter.
Celgene shareholders will receive one Bristol-Myers Squibb share along with US$50 in cash for each Celgene share.
It's been four months since he told the health ministry about politically connected firms raking in billions as tendering agents.
When and where treatments exist, they are often expensive and place enormous financial strain on households and health systems.
DAP's Klang MP says prices may be artifically high if whistleblower's bombshell account about tenders being rigged is true.
U.S. pharmaceutical giant Merck & Co. is planning for the possibility of a temporary supply blackout when the U.K. leaves the European Union and may stockpile as much as six months worth of goods and revise trade routes in preparation.
River systems around world are coursing with over-the-counter and prescription drug waste harmful to the environment, researchers said Tuesday.
'There's no evidence to support the allegation that intellectual property protection will adversely affect healthcare.'
Kelantan health authorities find 33 Facebook pages and Instagram accounts advertising medical products without prior approval from the Medicine Advertisements Board, which is an offence under the Medicines (Advertisement and Sale) Act 1956.
Brunei has also developed its very own guidelines and standards for the handling and manufacturing of halal pharmaceutical products.
The negotiating groups are exploring further options on challenging subjects of intellectual property, environment and state-owned enterprises.